BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quadeer AA, Louie RHY, McKay MR. Identifying immunologically-vulnerable regions of the HCV E2 glycoprotein and broadly neutralizing antibodies that target them. Nat Commun 2019;10:2073. [PMID: 31061402 DOI: 10.1038/s41467-019-09819-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Liu Z, Li C, Gil S, Papayannopoulou T, Doering CB, Lieber A. High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells. Blood Adv 2019;3:2883-94. [PMID: 31585952 DOI: 10.1182/bloodadvances.2019000706] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
2 Sohail MS, Louie RHY, McKay MR, Barton JP. MPL resolves genetic linkage in fitness inference from complex evolutionary histories. Nat Biotechnol 2021;39:472-9. [PMID: 33257862 DOI: 10.1038/s41587-020-0737-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Quadeer AA, Barton JP, Chakraborty AK, McKay MR. Deconvolving mutational patterns of poliovirus outbreaks reveals its intrinsic fitness landscape. Nat Commun 2020;11:377. [PMID: 31953427 DOI: 10.1038/s41467-019-14174-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
4 Quadeer AA, McKay MR, Barton JP, Louie RHY. MPF-BML: a standalone GUI-based package for maximum entropy model inference. Bioinformatics 2020;36:2278-9. [PMID: 31851308 DOI: 10.1093/bioinformatics/btz925] [Reference Citation Analysis]
5 Mosa AI, Urbanowicz RA, AbouHaidar MG, Tavis JE, Ball JK, Feld JJ. A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice. Vaccine 2020;38:6864-7. [PMID: 32900542 DOI: 10.1016/j.vaccine.2020.08.066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Sohail MS, Ahmed SF, Quadeer AA, McKay MR. In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives. Adv Drug Deliv Rev 2021;171:29-47. [PMID: 33465451 DOI: 10.1016/j.addr.2021.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
7 Mosa AI, AbouHaidar MG, Urbanowicz RA, Tavis JE, Ball JK, Feld JJ. Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV. Virol J 2020;17:140. [PMID: 32948191 DOI: 10.1186/s12985-020-01408-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ahmed SF, Quadeer AA, McKay MR. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses 2020;12:E254. [PMID: 32106567 DOI: 10.3390/v12030254] [Cited by in Crossref: 538] [Cited by in F6Publishing: 467] [Article Influence: 269.0] [Reference Citation Analysis]
9 Majid S, Farooq R, Khan MS, Rashid S, Bhat SA, Wani HA, Qureshi W. Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses. SN Compr Clin Med 2020;:1-10. [PMID: 32864575 DOI: 10.1007/s42399-020-00457-z] [Reference Citation Analysis]